Literature DB >> 23173724

Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis.

Baodong Qin1, Fenglou Huang, Yan Liang, Zaixing Yang, Renqian Zhong.   

Abstract

BACKGROUND AND AIM: MicroRNA, as an important regulator of gene expression, has been found to be associated with several diseases. MicroRNA expression profiles have been identified in several autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis. However, the expression profile in peripheral blood mononuclear cells (PBMCs) from primary biliary cirrhosis (PBC) patients and the role of microRNA in PBC remained unclear. The present study aimed to explore abnormal microRNA regulation in PBC.
METHODS: MicroRNA array was performed in PBMCs obtained from PBC patients versus healthy controls. Then, six of the 17 differentially expressed microRNAs were confirmed using quantitative real-time polymerase chain reaction. Based on bioinformatics analysis, we identified the potential biological processes and significant signaling pathways affected by these microRNAs, and generated the microRNA-gene network.
RESULTS: According to microRNA array, a total of 17 microRNAs were found to be differentially expressed. Six microRNAs have been validated using quantitative real-time polymerase chain reaction, and the results were consistent with microRNA array analysis. The bioinformatics analysis showed that the potential target genes of these microRNAs were involved in cell proliferation, cell differentiation, apoptosis, and signal transduction. Similarly, these microRNAs also affected endocytosis, mitogen-activated protein kinase signaling pathway, transforming growth factor-β signaling pathway, Wnt signaling pathway, calcium signaling pathway, etc.
CONCLUSION: In the present study, 17 microRNAs were identified to be differentially expressed in PBMCs from PBC patients. Functional bioinformatics analysis demonstrated that prediction genes targeted by these microRNAs were involved in multiple biological processes and signaling pathways. The present study offers intriguing new perspectives on the involvement of microRNA in PBC, but the precise mechanisms need to be validated further.
© 2012 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23173724     DOI: 10.1111/jgh.12040

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  15 in total

1.  MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation.

Authors:  Oihane Erice; Patricia Munoz-Garrido; Javier Vaquero; Maria J Perugorria; Maite G Fernandez-Barrena; Elena Saez; Alvaro Santos-Laso; Ander Arbelaiz; Raul Jimenez-Agüero; Joaquin Fernandez-Irigoyen; Enrique Santamaria; Verónica Torrano; Arkaitz Carracedo; Meenakshisundaram Ananthanarayanan; Marco Marzioni; Jesus Prieto; Ulrich Beuers; Ronald P Oude Elferink; Nicholas F LaRusso; Luis Bujanda; Jose J G Marin; Jesus M Banales
Journal:  Hepatology       Date:  2018-02-21       Impact factor: 17.425

Review 2.  Recent advances in the morphological and functional heterogeneity of the biliary epithelium.

Authors:  Yuyan Han; Shannon Glaser; Fanyin Meng; Heather Francis; Marco Marzioni; Kelly McDaniel; Domenico Alvaro; Julie Venter; Guido Carpino; Paolo Onori; Eugenio Gaudio; Gianfranco Alpini; Antonio Franchitto
Journal:  Exp Biol Med (Maywood)       Date:  2013-05

3.  MicroRNAs in Cholangiopathies.

Authors:  Steven P O'Hara; Sergio A Gradilone; Tetyana V Masyuk; James H Tabibian; Nicholas F LaRusso
Journal:  Curr Pathobiol Rep       Date:  2014-09-01

Review 4.  MicroRNAs in liver disease.

Authors:  Gyongyi Szabo; Shashi Bala
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-05-21       Impact factor: 46.802

Review 5.  Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity.

Authors:  Yu-Qing Xie; Hong-Di Ma; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

6.  Serum microRNAs as potential biomarkers of primary biliary cirrhosis.

Authors:  Youwen Tan; Tengli Pan; Yun Ye; Guohong Ge; Li Chen; Danfeng Wen; Shengqiang Zou
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

Review 7.  Emerging Role and Therapeutic Implication of Wnt Signaling Pathways in Autoimmune Diseases.

Authors:  Juan Shi; Shuhong Chi; Jing Xue; Jiali Yang; Feng Li; Xiaoming Liu
Journal:  J Immunol Res       Date:  2016-03-27       Impact factor: 4.818

Review 8.  MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment.

Authors:  Maria Jose Lorenzo Pisarello; Lorena Loarca; Tommy Ivanics; Leslie Morton; Nicholas LaRusso
Journal:  J Clin Med       Date:  2015-08-26       Impact factor: 4.241

9.  Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis.

Authors:  Kiyoshi Migita; Atsumasa Komori; Hideko Kozuru; Yuka Jiuchi; Minoru Nakamura; Michio Yasunami; Hiroshi Furukawa; Seigo Abiru; Kazumi Yamasaki; Shinya Nagaoka; Satoru Hashimoto; Shigemune Bekki; Hiroshi Kamitsukasa; Yoko Nakamura; Hajime Ohta; Masaaki Shimada; Hironao Takahashi; Eiji Mita; Taizo Hijioka; Haruhiro Yamashita; Hiroshi Kouno; Makoto Nakamuta; Keisuke Ario; Toyokichi Muro; Hironori Sakai; Kazuhiro Sugi; Hideo Nishimura; Kaname Yoshizawa; Takeaki Sato; Atsushi Naganuma; Tatsuji Komatsu; Yukio Oohara; Fujio Makita; Minoru Tomizawa; Hiroshi Yatsuhashi
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

Review 10.  Recent advances in the diagnosis and treatment of primary biliary cholangitis.

Authors:  Ying-Qiu Huang
Journal:  World J Hepatol       Date:  2016-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.